Evaluation of in vitro inhibitory effect of selected plants and Shilajit on HIV-Reverse transcriptase

Indian Journal of Natural Products and Resources

Volumn 3, Issue 2, 2012, Pages 145-151

  Rege, Anuya A ^a   Ambaye, Ramkrishna Y ^b   Deshmukh, Ranjana A ^a  

^a Haffkine Institute for Training Research and Testing India   (India)

^b INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

Anti HIV; HIV reverse transcriptase (RT); Mangroves; Medicinal plants; RT inhibition; Shilajit

Indexed keywords

EID: 84865043681     PISSN: 09760504     EISSN: 09760512     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Asres K, Seyoum A, Veeresham C, Bucar F and Gibbons S, Naturally derived anti-HIV agents, Phytother Res, 2005, 19(7), 557-581.
2. Kokate C K, Purohit A P and Gokhale S B, Drugs of mineral origin, In: Pharmacognosy, Nirali Prakashan, Pune, 2002, pp. 560-568.
3. Meena H, Pandey H K, Arya M C and Ahmed Z, Shilajit: A panacea for high-altitude problems, Int J Ayurv Res, 2010, 1(1), 37-40.
4. Agarwal S P, Khanna R, Karmarkar R, Anwer M K and Khar R K, Shilajit: A Review, Phytother Res, 2007, 21, 401-405.
5. http://ayurveda-foryou.com/ayurveda_herb/tulsi.html.
6. Mishra L, Singh B B and Dagenais S, Scientific basis for the therapeutic use of Withania somnifera (Ashwagandha): A review, Altern Med Rev, 2000, 5(4), 334-346.
7. Singh S S, Pandey S C, Srivastava S, Gupta V S, Patro B and Ghosh A C, Chemistry and medicinal properties of Tinospora cordifolia (Guduchi), Indian J Pharmacol, 2003, 35, 83-91.
8. http://www.aims.gov.au/pages/research/mangroves/mangr ove-biocom.html.
9. Premanathan M, Nakashima H, Kathiresan K, Rajendran N and Yamamoto N, In vitro anti human deficiency virus activity of mangrove plants, Indian J Med Res, 1996, 103, 278-281.
10. Chopra R N, Nayer S L and Chopra I C, Glossary of Indian medicinal plants, CSIR, New Delhi, 1992, pp.31, 212-213.
11. Asolkar L V, Kakkar K K and Chakre O J, Second supplement to glossary of Indian medicinal plants with active principles: Part-I (A-K), CSIR, New Delhi, 1992, p.108.
12. Dhawan B N, Dubey M P, Mehrotra B N, Rastogi R P and Tandon J S, Sceening of Indian plants for biological activity: Part IX, Indian J Exp Biol, 1980, 18, 594-606.
13. Agoramoorthy G, Chen F, VenkatesaluV, Kuo D and Shea P, Evaluation of antioxidant polyphenols from selected mangrove plants of India, Asian J Chem, 2008, 20(2), 1311-1322.
14. Rege A A, Ambaye R Y and Deshmukh R A, In vitro testing of Shilajit for Anti-HIV activity, Int J Pharmacol Biol Sci, 2009, 3(2), 57-64.
15. Rege A A, Ambaye R Y and Deshmukh RA, In vitro testing of Anti-HIV activity of some medicinal plants, Indian J Nat Prod Resour, 2010, 1(2), 193-199.
16. Bot Y S, Mgbojikwe L O, Nwosu C, Abimiku A, Dadik J and Damshak D, Screening of the fruit pulp extract of Momordica balsamina for anti HIV property, Afr J Biotechnol, 2007, 6(1), 47-52.
17. Indian Herbal Pharmacopoeia-A joint publication of RRL Jammu Tawi and IDMA, Mumbai, 1998, Vol. I, p. 180.
18. Tersmette M, Koot M, De Goede R E Y, Kootstra N and Schuitemaker H, Isolation and biological characterization of primary HIV-1 isolates, In: HIV a practical approach, by J Karn (Ed), IRL Press, 1995, Vol. 1, pp. 47-61.
19. Pengsuparp T, Chai L, Fong H H S, Kinghorn A D and Pezzuto J M, Pentacyclic triterpenes derived from Maprounea africana are potent inhibitors of HIV-1 reverse transcriptase, J Nat Prod, 1994, 57(3), 415-418.
20. Asres K, Bucar F, Kartnig T, Witvrouw M, Pannecouque C and De Clercq E, Antiviral activity against human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) of ethnobotanically selected Ethiopian medicinal plants, Phytother Res, 2001, 15, 62-69.
21. Patwardhan B, Vaidya A B and Chorghade M, Ayurveda and natural products drug discovery, Curr Sci, 2004, 86(6), 789-799.
22. Bhattacharya S K, Bhattacharya A and Chakrabarti A, Adaptogenic activity of Siotone, a polyherbal formulation of Ayurvedic rasayanas, Indian J Exp Biol, 2000, 38, 119-128.
23. Dahanukar S and Thatte U, State of the Art, In: Ayurveda Revisited, Popular Prakashan, Mumbai, 2000, pp. 131-145.
24. Bandaranayake W M, Traditional and Medicinal uses of Mangroves, Man and Salt Marsh, 1998, 2, 133-148.
25. Fiscus S A, DeGruttola V, Gupta P, Katzenstein D A, Meyer W A, LoFaro M L, Katzman M, Ragni M V, Reichelderfer P S and Coombs R W, Human immunodeficiency virus type 1 quantitative cell microculture as a measure of antiviral efficacy in a multicenter clinical trial, J Infect Dis, 1995, 171(2), 305-311.
26. Levy J A and Shimabukuro J, Recovery of AIDS-associated retroviruses from patients with AIDS or AIDS-related conditions and from clinically healthy individuals, J Infect Dis, 1985, 152, 734-738.
27. Salahuddin S Z, Markham P D, Popovic P M, Sarngadharan M G, Orndorff S, Fladagar A, Patel A, Gold J and Gallo R C, Isolation of infectious HTLV-III from AIDS and ARC patients and healthy carriers: A study of risk factors and tissue sources, Proc Natl Acad Sci USA, 1985, 82, 5530-5534.
28. Bessong P O, Obi C L, Igumbor E, Andreola M and Litvak S, In vitro activity of three selected South African medicinal plants against human immunodeficiency virus type 1 reverse transcriptase, Afr J Biotechnol, 2004, 3(10), 555-559.
29. EL-Mekkawy S, Meselhy M R, Kusumoto I T, Kadota S, Hattori M and Namba T, Inhibitory effects of Egyptian folk medicines on human immunodeficiency virus (HIV) reverse transcriptase, Chem Pharm Bull, 1995, 43(4), 641-648.
30. Rukunga G M, Kofi-Tsekpo M W, Kurokawa M, Kageyama S, Mungai G M, Muli J M, Tolo F M, Kibaya R M, Muthaura C N, Kanyara J N, Tukei P M and Shiraki K, Evaluation of HIV-1 reverse transcriptase inhibitory properties of extracts from some medicinal plants in Kenya, Afr J Health Sci, 2002, 9(1-2), 81-90.
31. thEdn, by C Hoffmann, J K Rockstroh and B S Kamps (Eds), Flying Publisher, 2007, pp. 89-271.
32. Chang C W, Linn M T, Lee S S, Liu K C S C, Hsu F-L and Lin J-Y, Differential inhibition of reverse transcriptase and cellular DNA polymerase-a-activities by lignins isolated from Chinese herbs Phyllanthus myrtifolium Moon and from Linocera japonica Thumb and Castanopsis hystrix, Antiviral Res, 1995, 27, 367-374.
33. Nakashima H, Kido Y, Kobayashi N, Motoki Y, Neushul M and Yamamoto N, Purification and characterization of an avian myeloblatosis and human immunodeficiency virus reverse transcriptase inhibitor, sulfated polysaccharides extracted from Sea algae, Antimicrob Agents Chemother, 1987, 31(10), 1524-1528.
34. McMahon J B, Currens M J, Gulakowski R J, Buckheit R W, Lackman-Smith C, Hallock Y F and Boyd M R, Michellamine B: A novel plant alkaloid, inhibits human immunodeficiency virus-induced cell killing by at least two distinct mechanisms, Antimicrob Agents Chemother, 1995, 39(2), 484-488.
35. Buckheit R W, White E L, Fliakas-Boltz V, Russell J, Stup T L, Kinjerski T L, Osterling M C, Weigand A and Bader J P, Unique Anti-human immunodeficiency virus activities of the non-nucleoside reverse transcriptase inhibitors calanolide A, costatolide and dihydrocostatolide, Antimicrob Agents Chemother, 1999, 43, 1827-1834.